Filtered By:
Condition: Heart Failure
Education: Study
Procedure: Coronary Artery Bypass Graft

This page shows you your search results in order of relevance. This is page number 16.

Order by Relevance | Date

Total 263 results found since Jan 2013.

A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention
CONCLUSIONS: CTO-PCI is associated with better subsequent clinical outcomes in observational studies but not in RCTs. Appropriately powered RCTs are needed to conclusively determine the impact of CTO-PCI on clinical outcomes.PMID:36227013
Source: The Journal of Invasive Cardiology - October 13, 2022 Category: Cardiology Authors: Bahadir Simsek Spyridon Kostantinis Judit Karacsonyi Khaldoon Alaswad Michael Megaly Dimitrios Karmpaliotis Amirali Masoumi Wissam A Jaber William Nicholson Stephane Rinfret Kambis Mashayekhi Gerald S Werner Margaret McEntegart Seung-Whan Lee Jaikirshan J Source Type: research

Outcomes of isolated CABG from “OPCAB favor institution” for patients with left ventricular dysfunction
ConclusionIn our institute, ONCAB was selected for the patients who could not complete treatment with OPCAB due to poor preoperative circulatory status. Our treatment policy for the patients with impaired cardiac function was acceptable.
Source: General Thoracic and Cardiovascular Surgery - December 3, 2022 Category: Cardiovascular & Thoracic Surgery Source Type: research

Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial
AbstractPurpose of ReviewThe Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) demonstrated the clinical benefit of the combination of ezetimibe-simvastatin compared to placebo-simvastatin following acute coronary syndrome (ACS). This review highlights key findings from this study with particular attention to the practice-changing impact on guidelines for low-density lipoprotein cholesterol (LDL-C) reduction after ACS, especially among high-risk populations.Recent FindingsConsistent reductions in LDL-C have been reported with newer lipid-lowering therapies (proprotein convertase subtilisin/k...
Source: Current Atherosclerosis Reports - February 10, 2023 Category: Cardiology Source Type: research

The Impact of Complete Revascularization in Symptomatic Severe Left Ventricular Dysfunction between Coronary Artery Bypass Graft and Percutaneous Coronary Intervention
CONCLUSIONS: In patients with symptomatic (NYHA class ≥ 3) severe LV dysfunction and CAD, CABG brought less HF admission when compared to patients in the PCI group, but this did not differ when compared to the complete revascularization subgroup. Therefore, an extensive revascularization, achieved by CABG or PCI, is associated with a lower HF hospitalization rate during the 3-yearfollow-up period in such populations.PMID:36896424 | PMC:PMC9991473 | DOI:10.1155/2023/9226722
Source: Cardiology Research and Practice - March 10, 2023 Category: Cardiology Authors: Hsiu-Yu Fang Yen-Nan Fang Yin-Chia Chen Jiunn-Jye Sheu Wei-Chieh Lee Source Type: research